Results 251 to 260 of about 2,332,572 (294)

Treatment of interface keratitis with oral corticosteroids

Journal of Cataract and Refractive Surgery, 2002
To describe the results of treating interface keratitis using a combination of intensive topical and oral corticosteroids.Casey Eye Institute, Portland, Oregon, USA.Thirteen eyes treated for grade 2 to 3 interface keratitis using an oral corticosteroid (prednisone 60 to 80 mg) as well as an hourly topical corticosteroid were retrospectively reviewed ...
Scott M, MacRae, Larry F, Rich, Damien C, Macaluso   +2 more
openaire   +2 more sources

Biologics for oral corticosteroid-dependent asthma

Allergy and Asthma Proceedings, 2020
Background: Oral corticosteroid (OCS) dependent asthma is one of the severe asthma phenotypes that requires personalized treatment. Objective: To review the role of biologic treatments in OCS-dependent asthma. Methods: A nonsystematic review was performed of emerging multiple novel biologics for potential treatment of OCS-dependent asthma. Results:
openaire   +3 more sources

Corticosteroids in Asthma

Drugs, 1980
The outlook for the patient severely affected by asthma was greatly improved with the introduction of corticosteroid therapy in 1948. Nevertheless, the dramatic benefits for the patient were not without cost, owing to the many unwanted and occasionally devastating side effects associated with the use of oral or parenteral corticosteroids.
openaire   +2 more sources

Aerosol and Oral Corticosteroids in the Treatment of Asthma

1988
The cause of asthma is unknown. However, it is now thought that the major abnormality is an underlying inflammation of the airway wall which persists, to some extent, between attacks. This inflammation manifests itself as bronchial hyperresponsiveness (BHR) which can be measured by inhalation tests from which dose response curves are derived.
A J, Woolcock, C, Jenkins
openaire   +2 more sources

Bronchial inflammation in corticosteroid‐sensitive and corticosteroid‐resistant asthma at baseline and on oral corticosteroid treatment

Clinical & Experimental Allergy, 2002
SummaryBackground Pathophysiology of corticosteroid (CS)‐resistant asthma remains incompletely understood.Objective To determine if failure of asthma to clinically improve with CS is due to a defective response of airway bronchial inflammation to these drugs.Methods Twenty‐one asthmatics having a decreased baseline FEV1 that improved ≥ 30% with inhaled
J, Chakir, Q, Hamid, M, Bossé, L-P, Boulet, M, Laviolette   +4 more
openaire   +2 more sources

Oral corticosteroids in the treatment of ocular myasthenia gravis

Neurology, 1974
Eight patients with ocular myasthenia gravis unresponsive to anticholines-terase medications were treated with alternate-day prednisone. Seven of the eight showed significant and sustained improvement. The patients exhibited few side effects of steroid therapy, and none manifested neurologic deterioration after institution of the therapy.
K C, Fischer, R J, Schwartzman
openaire   +3 more sources

Complications of Oral Corticosteroid Use in Otolaryngology

Annals of Otology, Rhinology & Laryngology
Objective: Oral corticosteroids (OCS) are frequently prescribed by otolaryngologists. However, there are limited quantitative data on OCS-related adverse events (AEs) in otolaryngology. We sought to quantify OCS-related AEs in otolaryngology. Methods:
Margaret B. Mitchell, Alan D. Workman, Neil Bhattacharyya   +2 more
openaire   +2 more sources

The population risk of fractures attributable to oral corticosteroids

Pharmacoepidemiology and Drug Safety, 2005
AbstractPurposePrevious studies have indicated a relationship between oral corticosteroid use and the risk of fracture, although without population‐based comparators or exact dose information. The aim was to estimate the relative and population attributable risk (PAR) of admission for non‐traumatic fracture among users of corticosteroids.MethodsThe ...
Donnan, Peter T., Libby, Gillian, Boyter, Anne C., Thompson, Philip   +3 more
openaire   +4 more sources

Doxycycline or Oral Corticosteroids for Nasal Polyps

The Journal of Allergy and Clinical Immunology: In Practice, 2013
The study by Van Zele et al reports positive results for a randomized, double-blind, placebo-controlled trial that used either 20 days of doxycycline (200 mg the first day, followed by 100 mg daily) or 20 days of a tapering schedule of methyl prednisolone (32 mg on days 1-5, 16 mg on days 6-10, and 8 mg on days 11-20) for the treatment of nasal polyps.
openaire   +2 more sources

Safety of oral corticosteroids.

European journal of respiratory diseases. Supplement, 1983
Oral corticosteroids may be life-saving for symptoms of acute asthma, and short courses are often useful to relieve even less serious acute exacerbations when the patient has become inadequately responsive to bronchodilators. Adverse effects are rarely if ever associated with short courses of steroids used for this purpose.
openaire   +1 more source